DNS-SGN>98.0%(HPLC)1mg

4-(1H-PYRAZOL-4-YL)PIPERIDINE, 95.0%, 250mg

4-Bromo-5-((4-hydroxyphenethylamino)methyl)-2-methoxyphenol, 98%, 250mg

5-Bromo-2-iodobenzotrifluoride, 97.0%, 25g

Tert-butyl 4-((3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamoyl)piperazine-1-carboxylate, 98%, 1g

((2-Fluoro-6-(methoxymethoxy)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-yl)ethynyl)triisopropylsilane, 97%, 1g

4-(2-Methoxy-phenylsulfanyl)-butyric acid ethyl ester, 25g

Xylidine Ponceau 2R (C.I. 16150), 100 g

methyl 3-(2-methyl-1H-indol-1-yl)-3-oxopropanoate, 250mg

4-Bromo-2-methylbutan-2-ol, 95.0%, 1g

5'-O-DMT-PAC-dA, 100mg

(S)-Ethyl 3-(3-bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoate, 95%, 10g

3-Benzyl-5-bromopyrazin-2-amine, 95+%, 1g